Biodesix (BDSX) Accounts Payables (2019 - 2026)

Biodesix (BDSX) has reported Accounts Payables for 8 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.

• Accounts Payables for Q1 2026 came in at $3.7 million, up 24.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 24.82% YoY), and the FY2025 annual result was $3.1 million, up 40.38% from the prior year.
• Accounts Payables was $3.7 million for Q1 2026 at Biodesix, up from $3.1 million in the prior quarter.
• Over five years, Accounts Payables peaked at $3.7 million in Q1 2026 and troughed at $1.6 million in Q1 2023.
• Average Accounts Payables over 5 years is $2.6 million, with a median of $2.9 million recorded in 2023.
• Year-over-year, Accounts Payables tumbled 43.42% in 2022 and jumped 105.57% in 2024.
• Over 5 years, Accounts Payables stood at $1.7 million in 2022, then soared by 73.83% to $2.9 million in 2023, then decreased by 25.09% to $2.2 million in 2024, then soared by 40.38% to $3.1 million in 2025, then climbed by 18.54% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $3.7 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.